Bernstein Maintains Outperform on Insulet, Raises Price Target to $200
Benzinga Newsdesk 2 hours ago
Analyst RatingsNewsPrice Target
Bernstein analyst Lee Hambright maintains Insulet (NASDAQ:PODD) with a Outperform and raises the price target from $175 to $200.
Bernstein analyst Lee Hambright maintains Insulet (NASDAQ:PODD) with a Outperform and raises the price target from $175 to $200.